Rinri Therapeutics

Provider of regenerative stem cell-based therapies for the treatment of hearing loss

placeSheffield, England, United Kingdom calendar_todayFounded 2018 groups9 employees language rinri-therapeutics.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 38 times.

YearFilings
20222
20242
20252
20261

Social engagement

Social engagement: 4.6K social following, 2 posts in the last 12 months — around the industry typical range.

Investor mix

6 investors on record; lead investors include Boehringer Ingelheim Venture Fund, UCB Ventures.

Investor typeCountShare
Venture capital350%
Accelerator & incubator117%
Other / undisclosed233%
Coming soon